Abstract
Objective
The study aims to assess the cost-effectiveness of a personalised telehealth intervention to manage chronic disease in the long run.
Method
The Personalised Health Care (PHC) pilot study was a randomised trial with an economic evaluation alongside over 12 months. From a health service perspective, the primary analysis compared the costs and effectiveness of PHC telehealth monitoring with usual care. An incremental cost-effectiveness ratio was calculated based on costs and health-related quality of life. The PHC intervention was implemented in the Barwon Health region, Geelong, Australia, for patients with a diagnosis of COPD and/or diabetes who had a high likelihood of hospital readmission over 12 months.
Results
When compared to usual care at 12 months, the PHC intervention cost AUD$714 extra per patient (95%CI -4879; 6308) with a significant improvement of 0.09 in health-related quality of life (95%CI: 0.05; 0.14). The probability of PHC being cost-effective by 12 months was close to 65%, at willingness to pay a threshold of AUD$50,000 per quality-adjusted life year.
Conclusion
Benefits of PHC to patients and the health system at 12 months translated to a gain in quality-adjusted life years with a non-significant cost difference between the intervention and control groups. Given the relatively high set-up costs of the PHC intervention, the program may need to be offered to a larger population to achieve cost-effectiveness. Long-term follow-up is required to assess the real health and economic benefits over time.
Funder
State Government of Victoria
Publisher
Public Library of Science (PLoS)
Reference38 articles.
1. Australian Institute of Health and Welfare. Chronic disease overview. 2018 [cited 2021; Available from: https://www.aihw.gov.au/reports-data/health-conditions-disability-deaths/chronic-disease/overview.
2. Measuring and valuing productivity loss due to poor health: A critical review.;W. Zhang;Social Science & Medicine,2011
3. The health-related quality-of-life of chronic obstructive pulmonary disease patients and disease-related indirect burdens;H.S. Choi;Korean Journal of Internal Medicine,2020
4. Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015–2030;D. Schofield;Health & Social Care in the Community,2019
5. Centers for Disease Control and Prevention. Health and Economic Costs of Chronic Diseases,. 2021 April 2022]; Available from: https://www.cdc.gov/chronicdisease/about/costs/index.htm.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献